Trial Profile

A Phase 1 Study of Oral MLN9708 to Assess Drug-Drug Interaction With Ketoconazole, Relative Bioavailability, Food Effect, Drug-Drug Interaction With Rifampin, and Safety and Tolerability in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Nov 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Aug 2017 Results published in the Journal of Clinical Pharmacology
07 Aug 2017 Primary endpoint ( Ratio of geometric mean Cmax and AUC0-tlast of Capsule B formulation versus Capsule A formulation and 90% CI [ Time Frame: Cycle 1: Days 1-28 ] has been met, as per results published in the Journal of Clinical Pharmacology.
07 Aug 2017 Results (n=20) published in the Journal of Clinical Pharmacology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com